István Laszlovszky, PharmD
- 4Articles
- 40KReads
- 2014–2016Active
- 17Collaborators
- 413Citations
About
István Laszlovszky, PharmD, has published research focused on the clinical effects and safety of cariprazine in psychiatric conditions including schizophrenia, schizoaffective disorders, bipolar disorder, and major depressive disorder. His work includes randomized controlled trials evaluating cariprazine’s efficacy in acute schizophrenia exacerbations, bipolar mania, and as adjunctive treatment for inadequate response to antidepressants. He has collaborated frequently with co-authors such as Suresh Durgam and György Németh.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
